Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension

被引:8
|
作者
Hamaguchi, Yasuhito [1 ]
Fujimoto, Manabu [1 ]
Hasegawa, Minoru [1 ]
Matsushita, Takashi [1 ]
Takehara, Kazuhiko [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Dermatol, Kanazawa, Ishikawa 9208641, Japan
关键词
Systemic sclerosis; Pulmonary arterial hypertension; IL-12; Bosentan; ENDOTHELIN-1; INTERLEUKIN-12; CYTOKINES;
D O I
10.1016/j.jdermsci.2009.02.013
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:66 / 67
页数:2
相关论文
共 50 条
  • [1] SERUM LEVELS OF ENDOGLIN IN PATIENTS WITH SYSTEMIC SCLEROSIS AND ISOLATED PULMONARY ARTERIAL HYPERTENSION
    Ximena, C. P.
    Garces, M. F.
    Caminos, E.
    Iglesias, A.
    Restrepo, J. F.
    Quintana, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S126 - S126
  • [2] Bosentan treatment in pulmonary arterial hypertension secondary to systemic sclerosis
    Piludu, G.
    Nalli, E.
    Amoresano, D.
    Farci, M.
    Muttini, T.
    D'Aietti, I
    Mura, N.
    Loddo, M.
    Giacco, G.
    ALLERGY, 2008, 63 : 353 - 353
  • [3] Experience with bosentan in pulmonary arterial hypertension secondary to systemic sclerosis
    Caroline Barranco
    Nature Clinical Practice Rheumatology, 2006, 2 (4): : 181 - 181
  • [4] Bosentan Improves Skin Perfusion of Hands in Patients with Systemic Sclerosis with Pulmonary Arterial Hypertension
    Rosato, Edoardo
    Molinaro, Ilenia
    Borghese, Federica
    Rossi, Carmelina
    Pisarri, Simonetta
    Salsano, Felice
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (12) : 2531 - 2539
  • [5] Bosentan: A review of its use in pulmonary arterial hypertension and systemic sclerosis
    Oldfield V.
    Lyseng-Williamson K.A.
    American Journal of Cardiovascular Drugs, 2006, 6 (3) : 189 - 208
  • [6] Usefulness of Bosentan in the Prevention of Pulmonary Hypertension in Patients with Systemic Sclerosis
    Castellvi, Ivan
    Pilar Simeon, Carmen
    Paola Sarmiento, Monica
    Guillen, Alfredo
    Diaz-Torne, Cesar
    De Llobet Zubiaga, Josep Maria
    Casademont, Jordi
    Fonollosa, Vicent
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan
    Martynyuk, Tamila
    Zykov, Kirill
    Arkhipova, Olga
    Kobal, Ekaterina
    Chazova, Irina
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [8] Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
    Papaioannou A.I.
    Zakynthinos E.
    Kostikas K.
    Kiropoulos T.
    Koutsokera A.
    Ziogas A.
    Koutroumpas A.
    Sakkas L.
    Gourgoulianis K.I.
    Daniil Z.D.
    BMC Pulmonary Medicine, 9 (1)
  • [9] Long term treatment with bosentan for pulmonary arterial hypertension related to systemic sclerosis
    Cozzi, F
    Montisci, R
    Marotta, H
    Bobbo, F
    Favaro, M
    Tiso, F
    Ciprian, L
    Iliceto, S
    Todesco, S
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 297 - 297
  • [10] Treatment of severe pulmonary arterial hypertension related to systemic sclerosis: Experience with bosentan
    Ahmadi-Slmab, K
    Hellmich, B
    Gross, WL
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 294 - 294